Mindfulness-based Cognitive Therapy for Patients With Inflammatory Bowel Disease

NCT04646785 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2024-01-24

No results posted yet for this study

Summary

Considering the limited availability of psychosocial interventions for IBD, this study aims to investigate MBCT as an adjunctive treatment to treatment as usual to reduce psychological stress and improve sleep quality/regularity in patients with IBD who report elevated stress levels. The study will have a follow-up duration of 12 months from baseline.

Conditions

  • Inflammatory Bowel Diseases

Interventions

BEHAVIORAL

Mindfulness-based cognitive therapy + TAU

The proposed intervention is mindfulness-based cognitive therapy (MBCT), based on the protocol published by Segal, Williams and Teasdale. MBCT consists of eight weekly 2.5h group sessions, a six-hour silent day and daily home practice assignments guided by audio files. The program includes both formal and informal meditation exercises. Cognitive techniques include monitoring and scheduling of activities, identification of negative automatic thoughts and devising a relapse prevention plan. Psycho-education and interactive dialogue typically focus on stress management, balancing activities, and (lifestyle) strategies to stay well in the future (relapse prevention).

OTHER

Treatment as usual (TAU)

Treatment as usual (TAU) according Dutch and European IBD treatment guidelines. TAU focuses on pharmacological and surgical disease control, and prevention of complications.

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER
  • Jeroen Bosch Ziekenhuis

    collaborator OTHER
  • Rijnstate Hospital

    collaborator OTHER
  • Canisius-Wilhelmina Hospital

    collaborator OTHER
  • Donders Centre for Cognitive Neuroimaging

    collaborator OTHER
  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Anne Speckens, Dr. · Radboud University Medical Center

  • Loes Nissen, Dr. · Jeroen Bosch Ziekenhuis

  • Marloes Huijbers, Dr. · Radboud University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2023-10-03
Completion
2023-10-03

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04646785 on ClinicalTrials.gov